Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RVMD✓SelectedUSD · RVMDGSK vs RVMD performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs RVMD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
RVMD return
+419.8%
Excess return
-373.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioRVMDExcessAlpha
1D-0.1%-3.1%+3.1%+0.1%
7D-1.3%-16.6%+15.3%-0.5%
30D+2.7%-6.2%+9.0%+3.0%
3M+2.7%-18.1%+20.8%+3.6%
6M+3.3%+14.6%-11.2%+2.4%
YTD+6.5%+109.5%-103.0%+1.8%
1Y+10.7%+146.3%-135.6%+5.0%
3Y+64.4%+685.3%-620.9%+46.4%
5Y+46.7%+425.4%-378.7%+28.5%
All+46.7%+419.8%-373.1%+28.5%

Cumulative growth

Daily Returns

Daily percentage return beside RVMD.

Daily Out/Under-Performance

Portfolio return minus RVMD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RVMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded RVMD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling